Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
!!Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
HM2026-25 Relative Bioavailability and Bioequivalence Study of Ziftomenib Drug Products in Participants with Relapsed/Refractory AML with NPM1 Mutation, or with Relapsed/Refractory AML or MDS with Mutations Associated with MEIS1 Overexpression
Premnath, Naveen
(PI)
Medicine - Hematology, Oncology, Transplant
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
7/17/26
→
9/9/36
Funding
KURA ONCOLOGY, INC
View all
View less